MX2012008871A - Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria. - Google Patents

Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria.

Info

Publication number
MX2012008871A
MX2012008871A MX2012008871A MX2012008871A MX2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A
Authority
MX
Mexico
Prior art keywords
acne
adapalene
post
decrease
treatment
Prior art date
Application number
MX2012008871A
Other languages
English (en)
Inventor
Pascale Soto
Jean-Charles Dhuin
Nabil Kerrouche
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2012008871A publication Critical patent/MX2012008871A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición dermatológica que comprende una combinación de adapaleno y peróxido de benzoilo que está propuesta para el tratamiento del acné en una población no caucásica con una reducción de la hiperpigmentación post-inflamatoria, la formación de cicatrices queloides, las máculas hiperpigmentadas del acné o las lesiones quísticas.
MX2012008871A 2010-02-09 2011-02-03 Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria. MX2012008871A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30258210P 2010-02-09 2010-02-09
PCT/EP2011/051580 WO2011098391A1 (en) 2010-02-09 2011-02-03 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation

Publications (1)

Publication Number Publication Date
MX2012008871A true MX2012008871A (es) 2012-08-31

Family

ID=43734249

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008871A MX2012008871A (es) 2010-02-09 2011-02-03 Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria.

Country Status (7)

Country Link
US (1) US20130131177A1 (es)
EP (1) EP2533776A1 (es)
JP (1) JP2013518920A (es)
KR (1) KR20120118064A (es)
BR (1) BR112012019827A2 (es)
MX (1) MX2012008871A (es)
WO (1) WO2011098391A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027984A1 (en) 2006-08-29 2008-03-06 Isolagen Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
US20130203850A1 (en) * 2010-04-29 2013-08-08 Galderma Research & Development Method for treating scars with adapalene 0.3%
US20130236427A1 (en) * 2012-03-07 2013-09-12 Fibrocell Technologies, Inc. Topical Dermal Formulations and Methods of Personalized Treatment of Skin
US20150126608A1 (en) * 2012-05-25 2015-05-07 Galderma Research & Development Treatment of preadolescent moderate acne vulgaris
MX2016012623A (es) * 2014-04-01 2016-12-14 Galderma Res & Dev Combinacion de adapaleno y peroxido de benzoilo para tratar cicatrices de acne.
JP6526322B2 (ja) * 2015-08-20 2019-06-05 ソル − ゲル テクノロジーズ リミテッド 過酸化ベンゾイルおよびアダパレンを含む局所投与用組成物
WO2023068233A1 (ja) * 2021-10-18 2023-04-27 マルホ株式会社 活性阻害及び／又は産生抑制剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833841B1 (fr) 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
FR2837101B1 (fr) 2002-03-12 2004-07-02 Galderma Res & Dev Utilisation de l'acide 6-[1-adamantyl)-4-methoxyphenyl]-2- naphthoique pour le traitement de desordres dermatologiques
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8080537B2 (en) * 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
CA2724804A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases

Also Published As

Publication number Publication date
KR20120118064A (ko) 2012-10-25
JP2013518920A (ja) 2013-05-23
WO2011098391A1 (en) 2011-08-18
EP2533776A1 (en) 2012-12-19
US20130131177A1 (en) 2013-05-23
BR112012019827A2 (pt) 2016-05-17

Similar Documents

Publication Publication Date Title
MX2012008871A (es) Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria.
LT2450035T (lt) Adapaleno ir benzoilo peroksido derinys, skirtas uždegiminių aknės pažeidimų gydymui
EP2294669B8 (en) Direct current power combiner
HK1185819A1 (en) Hydrogen peroxide sterilization method
IL205905A0 (en) Stable dispersions of single and multiple graphene layers in solution
PL2464617T3 (pl) Sposób i instalacja do dostarczania nośnika energii opartego na węglowodorze, które wykorzystują udział metanolu wytworzony regeneracyjnie i udział metanolu, który jest wytworzony poprzez bezpośrednie utlenianie, lub poprzez częściowe utlenianie, lub poprzez reforming
ECSP13013117A (es) Métodos para tratar la esclerosis múltiple y preservar y/o aumentar el contenido de mielina.
EP2297847A4 (en) RF POWER AMPLIFIERS WITH LINEARIZATION
PL2255431T3 (pl) Napęd bezpośredni o małej bezwładności i dużej gęstości mocy
IL223032A0 (en) Ultra-high efficiency switching power inverter and power amplifier
ZA201303338B (en) Enzymatic peracid generation for use in hair care products
EP2329002A4 (en) CONCENTRATED HYDROGEN PEROXIDE DISINFECTION SOLUTIONS
TWI341078B (en) Cascode-cascade doherty power amplifier
EP2654695B8 (en) Enzymatic peracid generation for use in oral care products
GB201109529D0 (en) Improved electrocatalyst for hydrogen peroxide cathodes and electrolating process
EP2266214A4 (en) REDUCTION OF POWER TRANSMITTED OUT OF BAND
EP2603973B8 (de) Hochfrequenzleistungsverstärker mit doherty-erweiterung
EP2303812A4 (en) CARBON DIOXIDE AND OXYGEN PROCESS COMBINED FOR THE DEHYDROGENATION OF ETHYLBENZENE IN STYRENE
GB2470693B (en) Processor having reduced power consumption
HK1178468A1 (zh) 使用臭氧和過氧化氫的生物恐怖對抗
HK1255668A1 (zh) 用於治療皮膚病症的包含二吲哚基甲烷和類視黃醇的組合物
WO2011137456A9 (en) Methods and mechanisms involving hyperpigmentation particularly for african american skin
EP2408480A4 (en) TISSUE ABLATION GUIDED BY OPTICAL COHERENCE TOMOGRAPH
EP2396069A4 (en) ENDOSCOPIC PLIERS WITH REMOVABLE HANDLE
PL2114392T3 (pl) Zastosowanie adapalenu i nadtlenku benzoilu do długotrwałego leczenia trądziku młodzieńczego

Legal Events

Date Code Title Description
HH Correction or change in general